SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-001331
Filing Date
2024-01-04
Accepted
2024-01-04 16:02:04
Documents
1
Period of Report
2024-01-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm241809-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm241809-1_3seq1.xml 3 1510
  Complete submission text file 0001104659-24-001331.txt   2981
Mailing Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005
Business Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Issuer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O GELESIS, INC. 501 BOYLSTON ST., SUITE 6102 BOSTON MA 02116
Business Address
Maltz Elliot (Reporting) CIK: 0001640888 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34703 | Film No.: 24511734